131 related articles for article (PubMed ID: 3562044)
1. Influence of cephalosporines III generation with varying biliary excretion on fecal flora and emergence of resistant bacteria during and after cessation of therapy.
Guggenbichler JP; Allerberger FJ; Dierich M
Padiatr Padol; 1986; 21(4):335-42. PubMed ID: 3562044
[TBL] [Abstract][Full Text] [Related]
2. [Selection of physiologic bacterial flora by chemotherapeutic agents].
Allerberger F; Guggenbichler JP; Ausserer B; Fink FM; Dierich MP
Wien Klin Wochenschr; 1989 Mar; 101(7):233-6. PubMed ID: 2652892
[TBL] [Abstract][Full Text] [Related]
3. Influence of third-generation cephalosporins on aerobic intestinal flora.
Guggenbichler JP; Kofler J
J Antimicrob Chemother; 1984 Sep; 14 Suppl B():67-70. PubMed ID: 6094464
[TBL] [Abstract][Full Text] [Related]
4. Impact of cefotaxime and ceftriaxone on the bowel and vaginal flora after single-dose prophylaxis in vaginal hysterectomy.
Bräutigam HH; Knothe H; Rangoonwala R
Drugs; 1988; 35 Suppl 2():163-8. PubMed ID: 3135167
[TBL] [Abstract][Full Text] [Related]
5. Ceftriaxone: therapeutic results in various infections and kinetic studies.
Giamarellou HJ; Tsagarakis J; Petrikkos G; Mavroudis K; Veldekis D; Daikos GK
Arzneimittelforschung; 1984; 34(3):321-5. PubMed ID: 6329238
[TBL] [Abstract][Full Text] [Related]
6. [Effect of ceftriaxone on aerobic fecal flora in children].
Borderon JC; Rastegar A; Saliba E; Laugier J; Despert F
Pathol Biol (Paris); 1990 Sep; 38(7):716-8. PubMed ID: 2235086
[TBL] [Abstract][Full Text] [Related]
7. No significant difference between ceftriaxone and cefotaxime in the emergence of antibiotic resistance in the gut microbiota of hospitalized patients: A pilot study.
Pilmis B; Jiang O; Mizrahi A; Nguyen Van JC; Lourtet-Hascoët J; Voisin O; Le Lorc'h E; Hubert S; Ménage E; Azria P; Borie MF; Mahé A; Mourad JJ; Trabattoni E; Ganansia O; Zahar JR; Le Monnier A
Int J Infect Dis; 2021 Mar; 104():617-623. PubMed ID: 33453395
[TBL] [Abstract][Full Text] [Related]
8. Ceftriaxone therapy of meningitis and serious infections.
Steele RW
Am J Med; 1984 Oct; 77(4C):50-3. PubMed ID: 6093519
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial activity of ceftriaxone: a review.
Cleeland R; Squires E
Am J Med; 1984 Oct; 77(4C):3-11. PubMed ID: 6093515
[TBL] [Abstract][Full Text] [Related]
10. Ceftriaxone in the treatment of serious infections, particularly after surgery.
Scully BE; Neu HC
Am J Surg; 1984 Oct; 148(4A):35-40. PubMed ID: 6091479
[TBL] [Abstract][Full Text] [Related]
11. Effect of ciprofloxacin on fecal flora of patients with cystic fibrosis and other patients treated with oral ciprofloxacin.
Scully BE; Jules K; Chin NX; Neu HC
Am J Med; 1987 Apr; 82(4A):336-8. PubMed ID: 3578324
[TBL] [Abstract][Full Text] [Related]
12. The influence of third-generation cephalosporins on the aerobic intestinal flora.
Guggenbichler JP; Kofler J; Allerberger F
Infection; 1985; 13 Suppl 1():S137-9. PubMed ID: 4055044
[TBL] [Abstract][Full Text] [Related]
13. [Effect of long-term preventive use of TMPS on the composition and resistance behavior of aerobic fecal flora].
Allerberger F; Guggenbichler JP; Ausserer B; Dierich M; Fink FM
Padiatr Padol; 1987; 22(2):131-7. PubMed ID: 3112699
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation of ceftriaxone (R013-9904) in the treatment of septicemia caused by gram-negative bacilli].
Naessens A; Pierard D; Roels P; Lauwers S
Pathol Biol (Paris); 1983 May; 31(5):362-5. PubMed ID: 6312398
[TBL] [Abstract][Full Text] [Related]
15. [Modification of aerobic digestive flora in patients in intensive care during and after treatment with cefmenoxime].
Poisson DM; Martin P; Bidault C; Gueveler C
Pathol Biol (Paris); 1989 May; 37(5):350-2. PubMed ID: 2674867
[TBL] [Abstract][Full Text] [Related]
16. Cefotaxime: microbiology, pharmacology, and clinical use.
Dudley MN; Barriere SL
Clin Pharm; 1982; 1(2):114-24. PubMed ID: 6309465
[TBL] [Abstract][Full Text] [Related]
17. [The study of drug resistance in aerobic and anaerobic bacterial flora to selected antibacterial drugs].
Michalska W; Chylak J; Pietkiewicz K
Med Dosw Mikrobiol; 1996; 48(1-2):61-70. PubMed ID: 8926770
[TBL] [Abstract][Full Text] [Related]
18. Ceftriaxone against gram-negative and gram-positive bacteria: bactericidal and post-antibiotic effect.
Ravizzola G; Bonfanti C; Savoldi E; Turano A
Chemioterapia; 1985 Jun; 4(3):204-8. PubMed ID: 3875430
[TBL] [Abstract][Full Text] [Related]
19. Ecological consequences of broad spectrum versus narrow spectrum antibacterial therapy.
Norrby SR
Scand J Infect Dis Suppl; 1986; 49():189-95. PubMed ID: 3547623
[TBL] [Abstract][Full Text] [Related]
20. Ceftriaxone and Cefotaxime Have Similar Effects on the Intestinal Microbiota in Human Volunteers Treated by Standard-Dose Regimens.
Burdet C; Grall N; Linard M; Bridier-Nahmias A; Benhayoun M; Bourabha K; Magnan M; Clermont O; d'Humières C; Tenaillon O; Denamur E; Massias L; Tubiana S; Alavoine L; Andremont A; Mentré F; Duval X;
Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30936104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
